oncology management

Research in Review

High-Dose Treatment for Acute Lymphoblastic Leukemia Safe, Improves Survival

04/29/2016

JCP Editors

Initial results from a clinical trial have shown that high-dose methotrexate may be superior to standard, low-dose regimens without increasing toxicity for children and young adults with high-risk B-acute...

...

04/29/2016

Journal of Clinical Pathways

Nivolumab More than Doubles One-Year Overall Survival in Head/Neck Cancer

04/27/2016

JCP Editors

Treatment with nivolumab reduced the risk of death and improved one-year overall survival (OS) compared with investigator’s choice of therapy for patients with recurrent or metastatic head and neck squamous cell...

...

04/27/2016

Journal of Clinical Pathways

Genetic Biomarkers Predict Treatment Outcomes for Patients With Breast Cancer

04/25/2016

JCP Editors

Results from a clinical trial presented at the 2016 American Association for Cancer Research Annual Meeting (April 16-20; New Orleans, LA) identified two genetic biomarkers capable of predicting which patients with...

...

04/25/2016

Journal of Clinical Pathways

Research in Review

Aspirin Reduces Mortality by 20% in Patients With Colon Cancer

04/21/2016

JCP Editors

Adding aspirin to cancer treatment regimens can reduce mortality by 20% in patients with colon cancer, according to a meta-analysis published in PLOS One. Previous studies have linked low-dose aspirin use to a...

Adding...

04/21/2016

Journal of Clinical Pathways

Research in Review

Active Surveillance Poses Risk of Metastasis for Certain Patients With Prostate Cancer

04/19/2016

JCP Editors

A percentage of patients on active surveillance for clinically insignificant prostate cancer may be at risk of developing metastatic disease in the long term. A study published in The Journal of Urology has reported...

A...

04/19/2016

Journal of Clinical Pathways

Research in Review

PET-Guided Chemotherapy Improves Progression-Free Survival in Patients With Hodgkin Lymphoma

04/12/2016

JCP Editors

Using positron emission tomography (PET) imaging to guide chemotherapy may help to improve progression-free survival (PFS) for patients with advanced Hodgkin lymphoma (HL), according to a study conducted by the...

Using...

04/12/2016

Journal of Clinical Pathways

Interview

Devising Pathways Strategies That Maintain the Principles of Personalized Medicine

04/11/2016

JCP Editors

As clinical pathways are utilized by more institutions to provide standardized, evidence-based care for patients with cancer, these tools have demonstrated a clear ability to reduce costs,1 improve hospital...

As...

04/11/2016

Journal of Clinical Pathways

Research in Review

Wide Variability in Radiation Therapy Following Neoadjuvant Chemotherapy for Patients With Breast Cancer

04/08/2016

JCP Editors

A study conducted by members of the American College of Surgeons has identified a need for greater uniformity and guidelines regarding radiation therapy following neoadjuvant chemotherapy in patients with initial...

A...

04/08/2016

Journal of Clinical Pathways

Research in Review

Novel Precision Medicine Tool Effective for Tracking Mutation-Specific Patient Outcomes

04/08/2016

JCP Editors

Researchers have developed a novel tool for calculating and displaying the survival statistics of patients with cancer depending on their genetic profile, which could help practitioners to better track...

...

04/08/2016

Journal of Clinical Pathways

New NCCN Guidelines Advise More Physician-led Discussions of Sexual Dysfunction

04/07/2016

JCP Editors

Clinicians should take a more active role in discussing sexual dysfunction with their patients, according to updates to National Comprehensive Cancer Network (NCCN) guidelines, which were presented at the NCCN annual...

...

04/07/2016

Journal of Clinical Pathways